Rational basis for Trk inhibition therapy for prostate cancer. (Q53405123)

14 May 2018

title

Rational basis for Trk inhibition therapy for prostate cancer. (English)

1 reference

14 May 2018

1 reference

Weeraratna AT

1

1 reference

14 May 2018

Arnold JT

2

1 reference

14 May 2018

George DJ

3

1 reference

14 May 2018

DeMarzo A

4

1 reference

14 May 2018

Isaacs JT

5

1 reference

14 May 2018

publication date

1 October 2000

1 reference

14 May 2018

published in

The Prostate

1 reference

14 May 2018

volume

45

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

140-148

1 reference

14 May 2018

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Akt signaling: linking membrane events to life and death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Neurotrophin signal transduction by the Trk receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Expression of a Trk high affinity nerve growth factor receptor in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Signalling through the neurotrophin receptor p75NTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

A new human prostate carcinoma cell line, 22Rv1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

CEP-751 inhibits trk receptor tyrosine kinase activityin vitro and exhibits anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

Prostatic stromal cell phenotype is directly modulated by norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

release_xmisdyrmxbdf7bv2xj5ym375je

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xmisdyrmxbdf7bv2xj5ym375je

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 May 2018